EE05128B1 - Farmatseutiline kompositsioon ja preparaat, mis sisaldavad drospirenooni ja etinl”stradiooli, ning nende kombinatsiooni kasutamine farmatseutilise kompositsiooni valmistamiseks - Google Patents

Farmatseutiline kompositsioon ja preparaat, mis sisaldavad drospirenooni ja etinl”stradiooli, ning nende kombinatsiooni kasutamine farmatseutilise kompositsiooni valmistamiseks

Info

Publication number
EE05128B1
EE05128B1 EEP200200110A EEP200200110A EE05128B1 EE 05128 B1 EE05128 B1 EE 05128B1 EE P200200110 A EEP200200110 A EE P200200110A EE P200200110 A EEP200200110 A EE P200200110A EE 05128 B1 EE05128 B1 EE 05128B1
Authority
EE
Estonia
Prior art keywords
pharmaceutical composition
preparation
drospirenone
stradiol
ethinyl
Prior art date
Application number
EEP200200110A
Other languages
English (en)
Estonian (et)
Inventor
Heil Wolfgang
Hilman J�rgen
Lipp Ralph
Heithecker Renate
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05128(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Priority to EEP200900049A priority Critical patent/EE05317B1/xx
Publication of EE200200110A publication Critical patent/EE200200110A/xx
Publication of EE05128B1 publication Critical patent/EE05128B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200200110A 1999-08-31 2000-08-31 Farmatseutiline kompositsioon ja preparaat, mis sisaldavad drospirenooni ja etinl”stradiooli, ning nende kombinatsiooni kasutamine farmatseutilise kompositsiooni valmistamiseks EE05128B1 (et)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EEP200900049A EE05317B1 (et) 1999-08-31 2000-08-31 Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38627499A 1999-08-31 1999-08-31
EP99202826 1999-08-31
PCT/IB2000/001213 WO2001015701A1 (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Publications (2)

Publication Number Publication Date
EE200200110A EE200200110A (et) 2003-06-16
EE05128B1 true EE05128B1 (et) 2009-02-16

Family

ID=26153359

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200110A EE05128B1 (et) 1999-08-31 2000-08-31 Farmatseutiline kompositsioon ja preparaat, mis sisaldavad drospirenooni ja etinl”stradiooli, ning nende kombinatsiooni kasutamine farmatseutilise kompositsiooni valmistamiseks

Country Status (26)

Country Link
EP (4) EP1380301B1 (xx)
JP (2) JP4354667B2 (xx)
KR (2) KR101019361B1 (xx)
AT (3) ATE254464T1 (xx)
AU (4) AU780330B2 (xx)
BG (1) BG66114B1 (xx)
BR (1) BR0014159A (xx)
CY (3) CY1108990T1 (xx)
CZ (1) CZ300514B6 (xx)
DE (5) DE60042089D1 (xx)
DK (3) DK1598069T3 (xx)
EE (1) EE05128B1 (xx)
ES (3) ES2319750T3 (xx)
HK (3) HK1047247B (xx)
HR (1) HRP20070188B1 (xx)
HU (1) HU227207B1 (xx)
IL (1) IL148339A0 (xx)
ME (2) MEP36008A (xx)
NO (1) NO326860B1 (xx)
NZ (1) NZ517845A (xx)
PL (1) PL199028B1 (xx)
PT (3) PT1380301E (xx)
RS (3) RS50262B (xx)
SI (3) SI1598069T1 (xx)
TW (1) TWI276436B (xx)
WO (1) WO2001015701A1 (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1380301B1 (en) * 1999-08-31 2009-01-14 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and dropirenone for use as a contraceptive
JO2334B1 (en) * 2000-01-18 2006-06-28 باير شيرنغ فارما اكتنجيسيلشافت Drospirenone for hormone replacement therapy
DE60113809T2 (de) * 2000-01-18 2006-06-22 Schering Ag Pharmazeutische kombination aus mikronisiertem drospirenon und einen estrogen für die hormonersatztherapie
JP5350572B2 (ja) * 2000-12-20 2013-11-27 バイエル ファーマ アクチエンゲゼルシャフト シクロデキストリン−ドロスピレノン封入複合体
EP1216713A1 (en) 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
NZ548754A (en) * 2002-04-26 2008-06-30 Schering Aktiengellschaft Treatment of hypertension in women receiving hormone replacement therapy
US7786101B2 (en) 2002-11-05 2010-08-31 Bayer Schering Pharma Ag Cardiovascular protection using anti-aldosteronic progestins
JP2007528388A (ja) * 2004-03-10 2007-10-11 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 分子分散されたドロスピレノンを含む組成物
MY142989A (en) 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
JP2008534522A (ja) * 2005-03-30 2008-08-28 ジェンファーム インク 医薬組成物のための複合ステップ製造方法
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
EP1767194A1 (de) * 2005-06-09 2007-03-28 Helm AG Verfahren zur Herstellung von Adsorbaten des Drospirenons
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
US20100086599A1 (en) * 2006-09-16 2010-04-08 Kairosmed Gmbh Oral modified release formulations
EP1900359A1 (en) * 2006-09-16 2008-03-19 KAIROSmed GmbH Oral modified release formulations containing drospirenon and 8-prenylnaringenin for use in female contraception
BRPI0810049A2 (pt) * 2007-04-05 2015-05-05 Bayer Schering Pharma Ag Regime de drospirenona/17beta-estradiol, produto de combinação farmacêutica e kit para realizar esse regime
HUP0700826A3 (en) 2007-12-20 2010-03-29 Richter Gedeon Nyrt Coated tablet containing drospirenone and process for producing the same
WO2009112231A2 (en) * 2008-03-10 2009-09-17 Schuermann Rolf New drospirenone/17beta-estradil regimen, pharmaceutical combination product and kit for performing this regimen
WO2009112232A2 (en) * 2008-03-10 2009-09-17 Vladimir Hanes New drospirenone/17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
US20120064166A1 (en) * 2009-02-18 2012-03-15 Bayer Pharma Aktienesellschaft Formulation comprising drospirenone for subcutaneous or intramuscular administration
UY32836A (es) 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
EA026095B1 (ru) * 2010-04-15 2017-03-31 Байер Интеллекчуал Проперти Гмбх Очень низкодозированные твердые пероральные лекарственные формы для гормонозаместительной терапии (гзт)
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
IT202100008834A1 (it) 2021-04-08 2022-10-08 Ind Chimica Srl Processo per la preparazione di drospirenone come polvere fine tramite duplice cambio di forma cristallina
WO2023152658A1 (en) 2022-02-10 2023-08-17 Lupin Limited Slow release drospirenone tablet composition
WO2023165988A1 (en) * 2022-03-01 2023-09-07 Chemo Research, S.L. Chewable oral contraceptive

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3051168C2 (de) * 1979-01-24 1998-08-27 Minnesota Mining & Mfg Mono- bzw. Polycarbonsäureester oder deren Gemische oder Ester bzw. deren Gemische aus Isocyanaten und fluor- bzw. chlorhaltigen aliphatischen Alkoholen
DE3051166C2 (en) 1980-06-11 1990-10-18 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De Compsns. for contraception or treatment of gynaecological disorders
DE3347125A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
DE3682130D1 (de) * 1985-07-15 1991-11-28 Japan Res Dev Corp Verfahren zur herstellung von ultrafeinen organischen verbindungen.
DE3916112A1 (de) 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE4227989A1 (de) 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DK95093D0 (da) * 1993-08-20 1993-08-20 Novo Nordisk As Farmaceutisk formulering indeholdende et hormon
ZA939566B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for dry blend compression od medicaments.
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
US5916593A (en) * 1994-09-22 1999-06-29 Akzo Nobel, N.V. Process of making dosage units by wet granulation
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US5897539A (en) * 1995-09-28 1999-04-27 Schering Aktiengesellschaft Hormone replacement therapy method and hormone dispenser
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
SI0917466T1 (en) * 1996-07-26 2005-02-28 Wyeth Oral contraceptive
AU3888697A (en) * 1996-07-26 1998-02-20 American Home Products Corporation Progestin/estrogen oral contraceptive
EP0956024B1 (en) * 1996-07-26 2004-07-21 Wyeth Monophasic oral contraceptive method and kit comprising a combination of progestin and estrogen
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
EP1380301B1 (en) * 1999-08-31 2009-01-14 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and dropirenone for use as a contraceptive
DE60113809T2 (de) * 2000-01-18 2006-06-22 Schering Ag Pharmazeutische kombination aus mikronisiertem drospirenon und einen estrogen für die hormonersatztherapie

Also Published As

Publication number Publication date
AU6589500A (en) 2001-03-26
HUP0202500A3 (en) 2004-04-28
EP1380301B1 (en) 2009-01-14
ES2211580T3 (es) 2004-07-16
CZ2002615A3 (cs) 2002-08-14
IL148339A0 (en) 2002-09-12
HK1047247A1 (en) 2003-02-14
KR20070067248A (ko) 2007-06-27
DK1598069T3 (da) 2009-07-06
JP4354667B2 (ja) 2009-10-28
AU2005202046A1 (en) 2005-06-09
DE122009000006I2 (de) 2012-03-22
SI1380301T1 (sl) 2009-06-30
RS20090134A (xx) 2009-11-10
EP2044941A1 (en) 2009-04-08
CY2009015I1 (el) 2014-02-12
AU2010226924A1 (en) 2010-10-28
PT1598069E (pt) 2009-07-20
EP1598069A2 (en) 2005-11-23
DE60041421D1 (de) 2009-03-05
NO326860B1 (no) 2009-03-02
RS50262B (sr) 2009-07-15
CZ300514B6 (cs) 2009-06-03
PT1214076E (pt) 2004-04-30
CY1109252T1 (el) 2014-07-02
DE122009000006I1 (de) 2009-05-07
EP1598069A3 (en) 2006-04-05
NZ517845A (en) 2004-12-24
ATE254464T1 (de) 2003-12-15
EP1214076B1 (en) 2003-11-19
SI1214076T1 (en) 2004-06-30
SI1598069T1 (sl) 2009-10-31
YU14502A (sh) 2006-01-16
NO20020801L (no) 2002-04-26
BG66114B1 (bg) 2011-05-31
ES2325589T3 (es) 2009-09-09
JP2003508441A (ja) 2003-03-04
KR100857344B1 (ko) 2008-09-05
DK1214076T3 (da) 2004-02-23
KR101019361B1 (ko) 2011-03-07
HRP20070188B1 (hr) 2015-06-19
PL354406A1 (en) 2004-01-12
DE60006692D1 (de) 2003-12-24
AU2005202046B9 (en) 2008-12-11
CY2009015I2 (el) 2014-02-12
ES2319750T3 (es) 2009-05-12
HK1061968A1 (en) 2004-10-15
DE60006692T2 (de) 2004-09-23
AU2005202046B2 (en) 2008-11-20
RS50262B2 (sr) 2018-10-31
PL199028B1 (pl) 2008-08-29
NO20020801D0 (no) 2002-02-19
HRP20070188A2 (en) 2007-07-31
DE122009000007I1 (de) 2009-05-07
HUP0202500A2 (en) 2002-10-28
EP1380301A1 (en) 2004-01-14
HU227207B1 (en) 2010-11-29
KR20020040798A (ko) 2002-05-30
AU2009200247B2 (en) 2010-07-01
MEP36008A (en) 2011-02-10
DE60042089D1 (de) 2009-06-04
EP1214076A1 (en) 2002-06-19
EE200200110A (et) 2003-06-16
PT1380301E (pt) 2009-03-30
ME00329B (me) 2011-05-10
AU2009200247A1 (en) 2009-02-19
CY1108990T1 (el) 2014-02-12
ATE429231T1 (de) 2009-05-15
DE122009000007I2 (de) 2011-07-21
AU780330B2 (en) 2005-03-17
HK1047247B (zh) 2004-07-23
DK1380301T3 (da) 2009-04-20
WO2001015701A1 (en) 2001-03-08
EP1598069B1 (en) 2009-04-22
TWI276436B (en) 2007-03-21
HK1082432A1 (en) 2006-06-09
JP2009143959A (ja) 2009-07-02
ATE420648T1 (de) 2009-01-15
BR0014159A (pt) 2002-05-07

Similar Documents

Publication Publication Date Title
EE05128B1 (et) Farmatseutiline kompositsioon ja preparaat, mis sisaldavad drospirenooni ja etinl”stradiooli, ning nende kombinatsiooni kasutamine farmatseutilise kompositsiooni valmistamiseks
EA200600884A1 (ru) Композиции комплексов экстроген-циклодекстрин
Schamschula et al. Fluoride and health: dental caries, osteoporosis, and cardiovascular disease
CA1300017C (en) Composition for preventing osteoporosis
US5026706A (en) Method for treating dysuria using naftopidil
RU2225714C2 (ru) Новый набор противозачаточных средств
PT1121109E (pt) Formulacao bifasica contendo tramadol
AU692155B2 (en) Method and composition for treatment of osteoporosis
EA200701091A1 (ru) Противозачаточный фармацевтический препарат
TH54054B (th) สารผสมทางเภสัชกรรมสำหรับใช้เป็นยาคุมกำเนิด
RU97113495A (ru) Применение 3,4-дифенил хроманов для получения фармацевтической композиции для лечения или профилактики идиопатической или физиологической гинекомастии
YU20050410A (sh) Kompozicije oksikodona sa kontrolisanim oslobađanjem

Legal Events

Date Code Title Description
HH1A Change of representative
AA1Y Spc filed

Free format text: PRODUCT NAME: YAZ; REG NO/DATE: 33842 29.06.2007

Spc suppl protection certif: C20090005

Filing date: 20090817

FG1Y Spc granted

Free format text: PRODUCT NAME: YAZ; REG NO/DATE: 33842 29.06.2007

Spc suppl protection certif: C20090005 00026

Filing date: 20090817

Extension date: 20220629

KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name
MF4A Right revoked following opposition or revocation
MC1Y Annulment of an spc

Spc suppl protection certif: 00026